Sera Prognostics Inc
Change company Symbol lookup
Select an option...
SERA Sera Prognostics Inc
CAC Camden National Corp
RE Everest Re Group Ltd
URRNF Twenty Seven Co Ltd
TWLV Twelve Seas Investment Co II
FLO Flowers Foods Inc
CAJ Canon Inc
WPC WP Carey Inc
PPT Putnam Premier Income Trust
GME GameStop Corp
Go

Health Care : Biotechnology |
Company profile

Sera Prognostics, Inc. is a women’s health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. The Company's commercial product, the PreTRM test, is a blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 19 or 20 of gestation. Its biomarker pregnancy pipeline includes preeclampsia, molecular time-to-birth, gestational diabetes mellitus (GDM), fetal growth restriction, stillbirth and postpartum depression.

Closing Price
$6.59
Day's Change
0.22 (3.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.94
Day's Low
5.75
Volume
(Below Average)
Volume:
43,980

10-day average volume:
54,204
43,980

Display:

Providers:

UpdateCancel
6 providers
December 15, 2021
SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX

Sera Prognostics Inc., The Pregnancy Company(R) (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it has been selected for addition...(PR Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.